Symptom trajectories during chemotherapy in patients with non‐small cell lung cancer (NSCLC) and the function of prolonging low dose dexamethasone in promoting enhanced recovery after chemotherapy

BACKGROUND: Lung cancer, mainly non‐small cell lung cancer (NSCLC), is one of the leading causes of death worldwide. Currently, chemotherapy is still the most significant treatment strategy for NSCLC. However, scant attention has been paid in previous studies to those patients who often experience v...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinghao, Liu, Xingyu, Dong, Ming, Zhao, Honglin, Li, Mei, Zhang, Hongbing, Ji, Huihui, Shi, Yi, Cui, Yajie, Wu, Di, Chen, Gang, Chen, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952786/
https://www.ncbi.nlm.nih.gov/pubmed/33496072
http://dx.doi.org/10.1111/1759-7714.13830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952786/
https://www.ncbi.nlm.nih.gov/pubmed/33496072
http://dx.doi.org/10.1111/1759-7714.13830

Ejemplares similares